Goldberg Segalla is pleased to announce the launch of a new blog: Life Science Matters — an inside look at the latest legal and regulatory developments arising out of the manufacturing and distribution of medical devices, pharmaceuticals, and other health-related products and services.
The life science, pharmaceutical, and medical device industries constantly evolve. Every day brings new discoveries and challenges, including a fast-moving legal and regulatory landscape. Goldberg Segalla’s Life Science Matters blog is focused on navigating this increasingly complex field and analyzing ways to evaluate and avoid risk. From case and regulatory analysis to news about medical, scientific, and business innovations, the Life Science Matters blog will break down what you need to know — and why.
The attorney contributors to the blog have dozens of years of experience representing clients in these highly regulated industries in all stages of business, from new product development and testing all the way through manufacturing, marketing, distribution, and advertising. They also counsel and represent U.S. and international companies of all sizes that are involved with the manufacturing and distribution of medical devices, over-the-counter drugs, pharmaceuticals, nutraceuticals, and other health-related products and services.
With this level of behind-the-scenes industry experience, the firm hopes visitors will find the blog to be a practical resource, and a useful forum in which to gain insight, participate in discussions, and keep abreast of all issues related to the life science and medical device industries.